2-溴-6-氯-4-甲基吡啶 | 157329-89-0

• 物质功能分类: 医药中间体 - 杂环化合物 - 吡啶类化合物
• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 中文名称: 2-溴-6-氯-4-甲基吡啶
• 英文名称: 2-bromo-6-chloro-4-methylpyridine
• CAS: 157329-89-0
• 化学式: C₆H₅BrClN
• 分子量: 206.469
• InChiKey: PDCBQYZKWWAKCG-UHFFFAOYSA-N

物化性质

• 沸点：
  262℃
• 密度：
  1.624
• 闪点：
  112℃

计算性质

• 辛醇/水分配系数(LogP)：
  3.2
• 重原子数：
  9
• 可旋转键数：
  0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.17
• 拓扑面积：
  12.9
• 氢给体数：
  0
• 氢受体数：
  1

安全信息

• 海关编码：
  2933399090
• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H335
• 储存条件：
  2-8°C，应保存在惰性气体中。

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 2-Bromo-6-chloro-4-picoline
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 2-Bromo-6-chloro-4-picoline
CAS number: 157329-89-0

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C6H5BrClN
Molecular weight: 206.5

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen chloride, hydrogen bromide.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  2-溴-6-氯-4-甲基吡啶 在 sodium chloride 作用下， 以 正己烷 、 乙酸乙酯 、 N,N-二甲基甲酰胺 为溶剂， 生成 6-氯-4-甲基-2-氰基吡啶
  参考文献：
  名称：

  Herbicidal picolinamide derivatives

  摘要：

  提供了具有以下公式的除草性吡啶甲酰胺衍生物，其中Z代表氧或硫原子，R.sup.1和R.sup.2分别独立地代表氢原子或可选择地取代的烷基、烯基、炔基、环烷基、环烷基烷基、芳基、芳基烷基、烷基芳基、羟基、烷氧基、烯基氧基、炔基氧基、烷基羰基、氨基、单或双烷基氨基、烷氧羰基氨基、芳基氨基、芳基烷基氨基或二烷基氨基甲酰基，或者一起代表一个可以被氧或硫原子或者由一个基团--NR--中断的烷基链，其中R代表氢原子或烷基，R.sup.3独立地代表卤素原子或烷基或卤代烷基，R.sup.4、R.sup.5和R.sup.6分别独立地代表氢或卤素原子，可选择地取代的烷基、烯基、炔基、环烷基、环烷基烷基、芳基、芳基烷基、烷基芳基、烷氧基、氨基、单或双烷基氨基、烷氧羰基氨基、芳基氨基、二烷基氨基、酰基或酰胺基团或氰基，但要求R.sup.5和R.sup.6不代表酰基、酰胺基或氰基团，n代表0、1、2或3。

  公开号：

  US05707932A1
• 作为产物：
  描述：

  2-氯-4-甲基吡啶 在 正丁基锂 、 N,N-二甲基乙醇胺 、 四溴化碳 作用下， 以 正己烷 、 四氢呋喃 为溶剂， 反应 2.0h， 以80%的产率得到2-溴-6-氯-4-甲基吡啶
  参考文献：
  名称：

  4-甲基吡啶和3,4-二甲基吡啶锂化过程中的侧链保留：轻松获得吡啶系列中的分子多样性

  摘要：

  4-甲基吡啶和3,4-二甲基吡啶的首次直接环选择性锂化是通过使用BuLi/LiDMAE聚集体来防止通常的侧链金属化实现的。通过环选择性顺序锂化在 C-2、C-6 和 C-5 位置引入了几种功能，为多取代吡啶构建块开辟了一条简单快速的途径。(© Wiley-VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany, 2003)

  DOI：

  10.1002/ejoc.200300243

文献信息

• [EN] GLP-1R MODULATING COMPOUNDS<br/>[FR] COMPOSÉS MODULATEURS DE GLP-1R
  申请人：GILEAD SCIENCES INC

  公开号：WO2021081207A1

  公开（公告）日：2021-04-29

  The present disclosure provides GLP-1R agonists, and compositions, methods, and kits thereof. Such compounds are generally useful for treating a GLP-1R mediated disease or condition in a human.

  本公开提供GLP-1R激动剂，以及其组合物、方法和试剂盒。这些化合物通常用于治疗人体中GLP-1R介导的疾病或症状。
• PYRIDINYL MODULATORS OF gamma-SECRETASE
  申请人：Lu Tianbao

  公开号：US20100022583A1

  公开（公告）日：2010-01-28

  The present invention relates to compounds of Formula I as shown below, wherein the definitions of A, X, R 1 R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , and R 9 are provided in the specification. Compounds of Formula I are useful for the treatment of diseases associated with γ-secretase activity, including Alzheimer's disease.

  本发明涉及如下所示的Formula I化合物，其中A、X、R1、R2、R3、R4、R5、R6、R7、R8和R9的定义在说明书中提供。Formula I化合物对于治疗与γ-分泌酶活性相关的疾病，包括阿尔茨海默病，具有用处。
• TGF BETA R ANTAGONISTS
  申请人：Bristol-Myers Squibb Company

  公开号：US20160176871A1

  公开（公告）日：2016-06-23

  The invention relates generally to compounds that modulate the activity of TGFβR-1 and TGFβR-2, pharmaceutical compositions containing said compounds and methods of treating proliferative disorders and disorders of dysregulated apoptosis, such as cancer, utilizing the compounds of the invention.

  这项发明通常涉及调节TGFβR-1和TGFβR-2活性的化合物，包含这些化合物的药物组合物以及利用该发明的化合物治疗增殖性疾病和失调凋亡疾病（如癌症）的方法。
• Herbicidal pyrazolyloxy-picolinamides
  申请人：American Cyanamid Company

  公开号：US05707933A1

  公开（公告）日：1998-01-13

  Herbicidal picolinamide derivatives are provided having the formula I ##STR1## which Z represents an oxygen or sulphur atom, R.sup.1 and R.sup.2 each independently represents a hydrogen atom or an optionally substituted alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, aryl, aralkyl, alkaryl, hydroxy, alkoxy, alkenyloxy, alkynyloxy, alkylcarbonyl, amino, mono- or di-alkylamino, alkoxycarbonylamino, arylamino, arylalkylamino or dialkylcarbamoyl group, or together represent an alkylene chain which is optionally interrupted by an oxygen, or sulphur atom or by a group --NR-- in which R represents a hydrogen atom or an alkyl group, R.sup.3 independently represents a halogen atom or an alkyl or haloalkyl group, R.sup.4, R.sup.5 and R.sup.6 each independently represents a hydrogen or halogen atom, an optionally substituted alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkylalkyl, aryl, aralkyl, alkaryl, alkoxy, amino, mono- or di-alkylamino, alkoxycarbonylamino, arylamino, dialkylcarbamoyl, acyl or acylamido group or a cyano group, with the proviso that R.sup.5 and R.sup.6 do not represent an acyl, acylamido or cyano group, and n represents 0, 1, 2 or 3.

  提供式I的除草杀草酰胺衍生物，其中Z代表氧或硫原子，R1和R2各自独立地代表氢原子或可选择取代的烷基，烯基，炔基，环烷基，环烷基烷基，芳基，芳基烷基，烷基芳基，羟基，烷氧基，烯基氧基，炔基氧基，烷基羰基，氨基，单烷基或二烷基氨基，烷氧羰基氨基，芳基氨基，芳基烷基氨基或二烷基氨基甲酰基，或共同代表可选择由氧或硫原子或由--NR--基团中的R代表氢原子或烷基组成的烷基链中断的烷基链，R3独立地代表卤原子或烷基或卤代烷基，R4，R5和R6各自独立地代表氢或卤原子，可选择取代的烷基，烯基，炔基，环烷基，环烷基烷基，芳基，芳基烷基，烷基芳基，烷氧基，氨基，单烷基或二烷基氨基，烷氧羰基氨基，芳基氨基，二烷基氨基甲酰基，酰基或酰胺基或氰基，但R5和R6不代表酰基，酰胺基或氰基，n代表0，1，2或3。
• Pyridinyl modulators of γ-secretase
  申请人：Janssen Pharmaceutica N.V.

  公开号：US07968725B2

  公开（公告）日：2011-06-28

  The present invention relates to compounds of Formula I as shown below, wherein the definitions of A, X, R1 R2, R3, R4, R5, R6, R7, R8, and R9 are provided in the specification. Compounds of Formula I are useful for the treatment of diseases associated with γ-secretase activity, including Alzheimer's disease.

  本发明涉及下式I的化合物，其中A、X、R1、R2、R3、R4、R5、R6、R7、R8和R9的定义在说明书中提供。式I的化合物对于治疗与γ-分泌酶活性相关的疾病，包括阿尔茨海默病，具有有用的作用。